ARRAY BIOPHARMA
  
 
Investor Relations Home  |   News   |   Events & Webcasts  |   SEC Filings & Reports  |   Stock Info  |   Analyst Coverage  |   Fundamentals  |   Earnings Estimates  |   FAQs  |   Information Request  |   Financial Tearsheet  |   Corporate Governance
 

Webcast ImageWebcast - Replay
Array BioPharma Inc. at UBS Global Healthcare Conference
05/21/13 at 8:30 a.m. ET
Receive E-mail AlertsE-mail Alerts
RSS Feeds RSS
Keyword Search
 
2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
 
12/19/07Topline Results Announced from a Phase 2 Study in Advanced Melonoma of Investigational Anti-Cancer Drug AZD6244 (ARRY-886)Printer Friendly Version
11/20/07Array BioPharma Advances p38 Inhibitor, ARRY-797, into Phase 2 Clinical TrialPrinter Friendly Version
11/20/07Array BioPharma to Present at the 19th Annual Piper Jaffray Health Care ConferencePrinter Friendly Version
11/05/07Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2008Printer Friendly Version
10/31/07Array BioPharma to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare ConferencePrinter Friendly Version
10/31/07Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2008 on November 5, 2007Printer Friendly Version
10/24/07Array BioPharma Reports Positive New Data on ErbB-2 / EGFR Inhibitor, ARRY-543Printer Friendly Version
10/22/07Array BioPharma to Present Clinical Data at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsPrinter Friendly Version
09/24/07Array BioPharma and Celgene Corporation Announce Strategic Global R&D CollaborationPrinter Friendly Version
09/17/07Array BioPharma to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
08/29/07Array BioPharma to Present at the Thomas Weisel Partners Healthcare ConferencePrinter Friendly Version
08/06/07Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2007Printer Friendly Version
08/03/07Array BioPharma Advances ErbB-2 Inhibitor, ARRY-380, into Phase 1 Cancer Patient TrialPrinter Friendly Version
08/02/07Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2007 on August 6, 2007Printer Friendly Version
07/05/07Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth ConferencePrinter Friendly Version
06/21/07Array BioPharma to Present at the Jefferies Healthcare ConferencePrinter Friendly Version
06/20/07Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory DrugsPrinter Friendly Version
06/06/07Array BioPharma to Present at the Needham Biotechnology & Medical Technology ConferencePrinter Friendly Version
05/30/07Array BioPharma to Present Clinical Data at the European League Against Rheumatism (EULAR) Annual Meeting and the 8th World Congress on InflammationPrinter Friendly Version
05/23/07Array BioPharma to Present at the Banc of America Securities Healthcare ConferencePrinter Friendly Version
05/15/07Array BioPharma Appoints John Yates, MB ChB, MD, to Chief Medical OfficerPrinter Friendly Version
05/08/07Array BioPharma Appoints Dr. Jonathan Kay to Its Scientific Advisory Board for Inflammation TherapyPrinter Friendly Version
05/03/07Array BioPharma Initiates Phase 1 Clinical Trial for Anticancer KSP Inhibitor ARRY-520Printer Friendly Version
05/01/07Array BioPharma Inc. Announces Pricing of Proposed Public Offering of Common StockPrinter Friendly Version
04/23/07Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2007Printer Friendly Version
04/23/07Array BioPharma Inc. Announces Proposed Public Offering of Common StockPrinter Friendly Version
04/18/07Array BioPharma Appoints Dr. Neil Spector to Its Scientific Advisory BoardPrinter Friendly Version
04/12/07Array BioPharma Achieves Milestone for Dosing MEK Inhibitor, ARRY-704, in Phase 1 Clinical TrialPrinter Friendly Version
04/10/07Array BioPharma Advances p38 Inhibitor, ARRY-797, into Phase 1 Cancer Patient TrialPrinter Friendly Version
03/14/07Array BioPharma to Present at the Lehman Brothers Annual Global Healthcare ConferencePrinter Friendly Version
03/13/07Array BioPharma and VentiRx Pharmaceuticals Announce License AgreementPrinter Friendly Version
02/06/07Array BioPharma to Present at the BIO CEO & Investor ConferencePrinter Friendly Version
02/05/07Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2007Printer Friendly Version
01/30/07Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2007 on February 5, 2007Printer Friendly Version

  Printer friendly version

Stock Quote
ARRY (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$5.85
Change (%) Stock is Up 0.19 (3.36%)
Volume547,693
Data as of 05/24/13 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock chart for: 03NA000000ARRY